MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...
Ken Olovich, R.Ph., MBA, Sourcing and Financial Director of Chorus, Eli Lilly, explains a model...
Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an...
Lisa Henry, Manager of Clinical Research, Cordis, discusses the merits of clinical trial outsourcing models
Ken Getz, Tufts CSDD, examines why the sponsor-CRO dynamic often falls short of expectations
James L. Sherley, M.D., Ph.D., Founder and Director, Asymmetrex, exposes a problem in the global...
Throughout this week, CTA will spotlight the ever-changing outsourcing landscape
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient...
Jeff Nelson, VP Program Management, Mateon Therapeutics, explores the rise of specialist payment providers